Fifth Third Bancorp
MRKR icon

Fifth Third Bancorp’s Marker Therapeutics MRKR Stock Holding History

Fifth Third Bancorp’s Portfolio MRKR Stock Details MRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.7K Hold
10,000
– – ﹤0.01% 3636
2026
Q1 		$13K Hold
10,000
– – ﹤0.01% 3630
2025
Q4 		$14.9K Buy
+10,000
New +$11.3K ﹤0.01% 1999
2019
Q1 		– Sell
-100
Closed -$6K – 2246
2018
Q4 		$6K Hold
100
– – ﹤0.01% 1920
2018
Q3 		$9K Buy
+100
New +$8.59K ﹤0.01% 1868

Other funds holding MRKR

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return

Fifth Third Bancorp's MRKR Position: Q2 2026 in Review

Fifth Third Bancorp held its Marker Therapeutics (MRKR) position steady in Q2 2026 at 10,000 shares worth $14.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3636.

Fifth Third Bancorp first reported a position in MRKR in Q3 2018 and has held it in 5 quarters since. The position peaked at $14.9K in Q4 2025. 35 funds tracked by Wall St. Rank hold MRKR as of Q2 2026.

  • Fifth Third Bancorp held 10,000 shares of Marker Therapeutics worth $14.7K as of Q2 2026.
  • Fifth Third Bancorp left its Marker Therapeutics share count unchanged in Q2 2026.
  • Marker Therapeutics made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #3636 holding.
  • Fifth Third Bancorp first reported a position in Marker Therapeutics in Q3 2018 and has held it in 5 quarters since.
  • Fifth Third Bancorp's Marker Therapeutics position peaked at $14.9K in Q4 2025.
  • 35 funds tracked by Wall St. Rank held Marker Therapeutics as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.